A wave of vital prescription drugs is about to get a lot cheaper for people on Medicare.

The Trump administration announced Tuesday that it has successfully negotiated lower prices for 15 drugs, including medications used for asthma, diabetes, arthritis and multiple forms of cancer. The list includes Ozempic and Wegovy, Novo Nordisk’s drugs for Type 2 diabetes and weight management, as well as Rybelsus, Novo’s oral GLP-1 for treating diabetes.

The deal for cheaper prescription drugs grew out of an initiative put in place by the Inflation Reduction Act, the signature legislative package passed in 2022 during the Biden administration. That law opened the door for Medicare to negotiate drug prices directly with pharmaceutical companies.

The first wave of those negotiations happened last ye

See Full Page